PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1688851
PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1688851
The global live cell imaging market is expected to grow at a CAGR of 8.79% from 2024 to 2030.
RECENT VENDORS ACTIVITIES
KEY TAKEAWAYS
MARKET TRENDS & DRIVERS
Leveraging AI and Big Data with Oblique Illumination Technology
The integration of big data and Artificial Intelligence (AI) completely changed the landscape of live cell optical imaging in recent years. AI and Big Data boost efficiency and expand the scope of insights gained. On another side, oblique illumination technology optimizes contrast, making cell structure sharper and enabling precise monitoring of changes during development and disease. Oblique illumination technology supports diverse applications, expanding its use in neuroscience, organ studies and 3D tissue cultures, vascular research, and pathology. The combination of big data analytics and AI algorithms also expands the application potential of new oblique illumination technology across various life sciences and drug discovery fields. With this ongoing trend in live cell imaging, AI and big data are expected to continue contributing to considerable progress in life sciences exploration.
Recent Advances in Fluorescent Probes for Live Cell Imaging
Live cell imaging with fluorescence microscopy has witnessed significant developments. It is a powerful and recognized technology for visualizing biological events in living cell samples with special resolution and high temporal. In addition, the development of fluorescent probes that emit far-red to near-infrared (NIR) fluorescence is beneficial for in-vivo imaging due to their low autofluorescence and high tissue permeability, as well as their suitability for multicolor imaging. This development of fluorescent probes and associated benefits are expected to deliver lucrative market growth opportunities.
Growing Demand for Live Cell Imaging In Drug Discovery
Live cell imaging is significantly useful for several aspects of the drug discovery and development pipeline such as kinetic studies and compound mode of action or to analyze the motion of cellular components. Furthermore, high-content imaging (HCI) and AI widely contribute to drug discovery and development, accelerated by the recent progress in deep neural networks. These factors are accelerating the demand for live cell imaging in drug discovery. For example, Revvity developed high-content screening systems, such as Operetta CLS and Opera Phenix offer significant flexibility to run live cell assays which are highly required and used in drug discovery programs.
Rising Application of Live-Cell Imaging in Disease Diagnosis
Live cell imaging applications rapidly growing in disease diagnosis with the increasing capabilities to understand the live cellular activities that help to understand the basics of disease biology, functional consequences of genetic, pharmacological, and or therapy intervention, and results in real-time. Recently, live cell imaging has become an invaluable tool in Central Nervous System (CNS) diseases and disorders as live cell imaging offers from basic diseases biology to the functional consequences of behavioral therapy interventions, genetic, and pharmacological interventions result in real-time.
SEGMENTATION INISIGHTS
INSIGHTS BY PRODUCT TYPE
The global live cell imaging market by product type is segmented into equipment, consumables, and software. In 2024, the equipment segment dominates and holds the largest market share of over 51%. In live-cell imaging equipment includes microscopes, image-capturing devices, and cell analyzers used for live-cell imaging. Live cell imaging equipment witnessed significant developments in recent years. The development of automated live-cell imaging equipment redefines research capabilities for biopharma companies and research and academic institutes. Automated live cell imaging systems provide multi-position imaging in both fluorescence microscopy and brightfield microscopy. It schedules a time-lapse function, and moving camera, and enables consistent, easy, and reliable results. Furthermore, advancements in digital image-capturing devices eliminate the complexities of cell imaging associated with traditional microscopes. These digital imaging devices allow users to visualize, capture, and store images and create multicolor overlays. These factors accelerate the market growth.
INSIGHTS BY TECHNIQUE
The global live cell imaging market by technique is categorized into fluorescence microscopy, confocal microscopy, transmitted light microscopy, and others. Fluorescence microscopy holds the largest market share and shows prominent growth, with the fastest-growing CAGR of 9.06% during the forecast period. Fluorescence microscopy is the most widely preferred and used technique for live-cell imaging due to its capability to mark, analyze, and imagine targeted cells. The fluorescence markers used in live cell imaging offer clear imaging of targeted as well as unwanted biological material that significantly helps researchers. Clear visuals and minimizing human errors are major properties of fluorescence techniques in live cell imaging. Furthermore, fluorescence microscopy in live cell imaging is now widely used for studying dynamic processes and time-lapse imaging of live cells can offer valuable and unique insights into events that may understand or unfold over hours or days.
INSIGHTS BY APPLICATION
Based on the application, the cell biology segment accounted for the largest share of the global live cell imaging market. Using live-cell imaging, researchers covered a range of cell biology topics, including investigation of cell migration, mimicking lymphatic or blood vessels, angiogenesis, cell proliferation, inter- and intracellular signaling, and many more. Globally, thousands of cell biology academic universities, research centers, and biopharma companies are engaged in cell biology research to identify the potential of cell biology to improve human lives and fuel the demand for live-cell imaging solutions. Furthermore, the growing funding for cell biology is one of the major factors accelerating the demand for live-cell imaging solutions.
INSIGHTS BY END-USER
The global live cell imaging market by end-user is segmented into pharma & biotech companies, academic & research institutes, and others. The pharma & biotech companies segment accounts for the largest market share in 2024. Pharma & biotech companies are actively engaged in drug discovery and significant spending on R&D. Pharma & biotech companies are conducting clinical trials that generate significant data that need to be collected, segregated, and structured where live-cell imaging software widely used for live cell imaging data storage and transfer. Most targeted biopharma companies for living-cell imaging solutions are those companies that are engaged in cell therapy research and development. The market is expanding as pharmaceutical and biotech companies increase research and development efforts, conduct a growing number of clinical trials, and focus more on personalized medicine. This rising emphasis on innovation is driving the demand for live-cell imaging solutions among biopharma companies.
GEOGRAPHICAL ANALYSIS
North America dominates and holds the largest share of over 35% of the global live cell imaging market. North America is home to several small, medium, and large market players that widely promote live-cell imaging equipment, software, and consumables for clinical research and development for biopharma companies and academic & research institutes/centers. The US and Canada are two major countries that are highly engaged in cell biology and associated research, fueling the demand for live cell imaging solutions. The demand for live cell imaging in North America has experienced a steady growth rate due to the increasing research and development (R&D) in cellular biology, rapid development in cell and gene therapies, and growing applications in disease diagnosis and therapy developments.
SEGMENTATION & FORECAST
COMPETITIVE LANDSCAPE
The global live cell imaging market report consists of exclusive data on 37 vendors. Agilent Technologies, BD, Danaher, PerkinElmer, MerckKgaA, Thermo Fisher Scientific, and Zeiss are some of the leading companies that accounted for the highest market share in the global live-cell imaging market. These vendors offer high-class and reliable live-cell imaging equipment, consumables, and software solutions that meet customers' requirements and international regulations. Leading vendors are increasing the efficiency of their products and strengthening their market position. These companies have a strong brand image and wide geographical reach across the global market. Also, the adoption of various strategies, such as product launches, new product development with advanced technologies and tools, and acquisitions intensified the competition in the market. The adoption of such strategies by the vendors and their focus on expanding their capabilities have enabled them to gain a higher revenue share in the market.
Key Vendors
Other Prominent Vendors
KEY QUESTIONS ANSWERED:
CHAPTER -1: Scope & Coverage: Live-cell Imaging Market Overview
CHAPTER - 2: Live-cell Imaging Market Premium Insights
CHAPTER - 3: Live-cell Imaging Market Prospects & Opportunities
CHAPTER - 4: Live-cell Imaging Market Industry Overview
CHAPTER - 5: Live-cell Imaging Market Segmentation Data
CHAPTER - 6: Key Regions Overview
CHAPTER - 7: Competitive Landscape of Live-cell Imaging Market
CHAPTER - 8: Appendix